Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human embryonic stem cells.

Cleo Choong1, Mahendra S Rao

  • 1Laboratory of Stem Cell Biology, Singapore Stem Cell Consortium, 11 Biopolis Way, Helios 01-02, Singapore 138667. cleo_choong@sscc.a-star.edu.sg

Neurosurgery Clinics of North America
|January 25, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multifunctional P(PEGMA)-REDV conjugated titanium surfaces for improved endothelial cell selectivity and hemocompatibility.

Journal of materials chemistry. B·2020
Same author

Preparation of a soft and interconnected macroporous hydroxypropyl cellulose methacrylate scaffold for adipose tissue engineering.

Journal of materials chemistry. B·2020
Same author

Endothelial cell thrombogenicity is reduced by ATRP-mediated grafting of gelatin onto PCL surfaces.

Journal of materials chemistry. B·2020
Same author

Bioactivated protein-based porous microcarriers for tissue engineering applications.

Journal of materials chemistry. B·2020
Same author

PCL microspheres tailored with carboxylated poly(glycidyl methacrylate)-REDV conjugates as conducive microcarriers for endothelial cell expansion.

Journal of materials chemistry. B·2020
Same author

Multifunctional REDV-conjugated zwitterionic polycarboxybetaine-polycaprolactone hybrid surfaces for enhanced antibacterial activity, anti-thrombogenicity and endothelial cell proliferation.

Journal of materials chemistry. B·2020
Same journal

Intramedullary Spinal Cord Tumors.

Neurosurgery clinics of North America·2026
Same journal

Spinal Cord Deformities Associated with Intramedullary Spinal Cord Tumors.

Neurosurgery clinics of North America·2026
Same journal

Radiation Therapy for Spinal Cord Tumors.

Neurosurgery clinics of North America·2026
Same journal

Treatment Strategies of Intramedullary Spinal Cord Tumors.

Neurosurgery clinics of North America·2026
Same journal

Vascular Lesions of the Spinal Cord: Arteriovenous and Cavernous Malformations.

Neurosurgery clinics of North America·2026
Same journal

Hemangioblastomas of the Spinal Cord.

Neurosurgery clinics of North America·2026
See all related articles

Human embryonic stem cells (hESCs) are a stable, renewable source for cell therapies. This review focuses on their use in neural target research and therapeutic applications.

Area of Science:

  • Stem Cell Biology
  • Regenerative Medicine

Background:

  • Human embryonic stem cells (hESCs) possess stable pluripotency, karyotype, gene expression, DNA repair, and telomerase levels.
  • hESCs provide a renewable source for diverse cell types crucial for research and cell-based therapies.
  • Characterizing differentiated cell populations from hESCs offers insights into early differentiation and aids downstream applications.

Purpose of the Study:

  • To review recent advancements in the field of human embryonic stem cells.
  • To focus on the application of embryonic stem cells for neural targets.

Main Methods:

  • Review of recent scientific literature and progress in hESC research.
  • Focus on strategies involving master and working cell banks for generating specific cell types.

Related Experiment Videos

  • Discussion of cell purification and enrichment techniques.

    • Main Results:

    • hESCs demonstrate consistent stability in key biological characteristics.
    • Established protocols for cell banking and differentiation are crucial for therapeutic development.
    • Purified hESC-derived populations are essential for screening, drug discovery, and therapeutic use.

    Conclusions:

    • Human embryonic stem cells are a valuable and stable resource for developing cell-based therapies.
    • The strategic use of cell banks and purification methods enhances the utility of hESCs.
    • Significant progress has been made in utilizing hESCs, particularly for neural applications.